Saturday - September 05, 2026

Category Archives: Science

Atopic Dermatitis Pipeline Gains Momentum: 100+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

Gurugram, Haryana, India – (September 02, 2026) –  DelveInsight’s “Atopic Dermatitis Pipeline Insight 2026” report provides comprehensive insights about 100+ companies and 120+ pipeline drugs in the Atopic Dermatitis pipeline landscape. It covers the Atopic Dermatitis Pipeline drug profiles, including … Continue reading →

Neuropathic Ocular Pain Therapeutics Market Size in the 7MM is projected to grow at a significant CAGR over the forecast period of 2026-2036 | DelveInsight

Gurugram, Haryana, India – (September 02, 2026) – DelveInsight’s ‘Neuropathic Ocular Pain Market Insights, Epidemiology and Market Forecast – 2036’ report delivers an in-depth understanding of the Neuropathic Ocular Pain, historical and forecasted epidemiology, as well as the Neuropathic Ocular … Continue reading →

Aplastic Anemia Market to Cross USD 300 Million by 2036 Amid Steady Reliance on Immunosuppressive Therapies and Emerging Cell-Based Approaches

(Albany, New York)- 2nd Sep 2026 – DelveInsight’s “Aplastic Anemia Market Insights, Epidemiology, and Market Forecast 2036” report provides comprehensive insights into the Aplastic Anemia market size, historical and forecasted epidemiology, current and emerging treatment landscape, and market opportunity across the … Continue reading →

Atopic Dermatitis Market is Projected to Witness Significant Growth by 2036 Owing to the Rising Disease Prevalence and Expansion of Targeted Biologics and JAK Inhibitors | DelveInsight

(Albany, New York)- 2nd Sep 2026 – The market dynamics for Atopic Dermatitis are witnessing significant growth driven by rising disease prevalence, increasing diagnosis rates, growing awareness of the disease burden, and the expanding adoption of targeted systemic therapies. Additionally, … Continue reading →

Short Bowel Syndrome Market is Projected to Witness Significant Growth by 2036 Owing to the Rising Burden of Gastrointestinal Conditions and Expansion of GLP-2 Analog Therapies | DelveInsight

(Albany, New York) – 2nd Sep 2026 – The market dynamics for Short Bowel Syndrome (SBS) are witnessing steady growth driven by increasing cases of conditions such as Crohn’s disease, necrotizing enterocolitis, and gastrointestinal surgeries, particularly among neonates and the elderly, … Continue reading →

Complement 3 Glomerulopathy Market is Projected to Witness Significant Growth by 2036 Owing to Advancements in Complement Biology and the Expansion of Targeted Complement Therapies | DelveInsight

The market dynamics for Complement 3 Glomerulopathy (C3G) are witnessing significant growth driven by increasing understanding of complement dysregulation, advancements in diagnostic capabilities, growing use of genetic testing and complement assays, and the expansion of targeted complement therapies. (Albany, New … Continue reading →

Peripheral T-cell Lymphoma Market is Projected to Witness Significant Growth by 2036 Owing to the Rising Disease Incidence and Expansion of Targeted Therapies | DelveInsight

(Albany, New York) – 2nd Sep 2026 – The market dynamics for Peripheral T-cell Lymphoma (PTCL) are witnessing steady growth driven by the rising incidence of PTCL, improved disease recognition and classification, advancements in molecular diagnostics, and the increasing need for … Continue reading →

Radiation-Induced Oral Mucositis in Prostate Cancer Market is Projected to Witness Significant Growth by 2036 Owing to the Rising Use of Radiotherapy and Growing Demand for Supportive Care | DelveInsi

(Albany, New York) – 2nd Sep 2026 – The market dynamics for Radiation-Induced Oral Mucositis in Prostate Cancer are witnessing steady growth driven by the rising incidence of prostate cancer, increasing utilization of radiotherapy, growing adoption of advanced radiation techniques such … Continue reading →

Atherosclerotic Cardiovascular Disease Market is Projected to Witness Significant Growth by 2036 Owing to the Rising Cardiovascular Disease Burden and Advancements in Lipid-Lowering Therapies | DelveI

(Albany, New York) – 2nd Sep 2026 – The market dynamics for Atherosclerotic Cardiovascular Disease (ASCVD) are witnessing steady growth driven by the rising global burden of cardiovascular diseases, increasing prevalence of dyslipidemia and metabolic disorders, growing awareness of cardiovascular … Continue reading →